Transcriptional control requires epigenetic changes directed by mitochondrial tricarboxylic acid (TCA) cycle metabolites. In the mouse embryo, global epigenetic changes occur during zygotic genome activation (ZGA) at the 2-cell stage. Pyruvate is essential for development beyond this stage, which is at odds with the low activity of mitochondria in this period. We now show that a number of enzymatically active mitochondrial enzymes associated with the TCA cycle are essential for epigenetic remodeling and are transiently and partially localized to the nucleus. Pyruvate is essential for this nuclear localization, and a failure of TCA cycle enzymes to enter the nucleus correlates with loss of specific histone modifications and a block in ZGA. At later stages, however, these enzymes are exclusively mitochondrial. In humans, the enzyme pyruvate dehydrogenase is transiently nuclear at the 4/8-cell stage coincident with timing of human embryonic genome activation, suggesting a conserved metabolic control mechanism underlying early pre-implantation development.
In Brief
Mitochondrial enzymes in the nucleus synthesize metabolites for epigenetic remodeling during zygote activation.
INTRODUCTION
Mammalian pre-implantation development initiates with the release of oocytes from the ovary, followed by fertilization resulting in a single-cell zygote. In mouse, the zygote undergoes three to four rounds of cell division, compacts at the 8-cell stage and then gives rise to a morula. The first differentiation step results in a blastocyst containing an inner cell mass (ICM) of cells, progenitors to the embryo proper and a surrounding lining of trophectoderm (TE) cells that will form extra-embryonic tissues. Preimplantation development takes approximately 4 days in mice and 6 days in humans, and the blastocyst then implants into the uterine wall (Cockburn and Rossant, 2010; Li et al., 2010) . The preimplantation embryo derives and exchanges nutrients with the oviductal fluid, while the post-implantation embryo is vascularized and is exposed to the considerably larger repertoire of nutrients and growth factors from the maternal blood supply. This developmental program is recapitulated ex vivo when the zygote is grown in a defined medium (potassium-supplemented simplex optimized medium [KSOM] ), most of whose components are present in the oviductal fluid (Lawitts and Biggers, 1991) . Such cultured embryos can be transplanted to produce normal progeny in diverse mammalian species (McLaren and Biggers, 1958) .
Several critical cellular events occur during the 1-cell and 2-cell stages of mouse pre-implantation development. By the end of the 2-cell stage, maternal endowments of most RNAs and some proteins are depleted, and development beyond this point requires the productive activation of the embryonic genome (Li et al., 2010) . Major zygotic/embryonic genome activation (ZGA/EGA) takes place at the 2-cell stage in mouse (Aoki et al., 1997) and EGA in humans, occurs during the 4-to 8-cell stage (Niakan and Eggan, 2013) . As expected, these processes are dependent on many structural and epigenetic changes to the maternal and the paternal genomes that are reprogrammed for the purpose of the embryo (Weaver et al., 2009 ). Such major reprogramming of the genome requires metabolites such as a-ketoglutarate (a-KG), essential for protein and DNA demethylation, acetyl-CoA required for protein acetylation, ATP for phosphorylation of substrates, and UDP-GlcNAc for glycosylation (Hardivillé and Hart, 2014; Martinez-Pastor et al., 2013) , production of each is dependent on the mitochondrial enzymes driving the tri-carboxylic acid (TCA) cycle and the utilization of pyruvate by pyruvate dehydrogenase. However, analysis of the early cleavage stages shows that the embryo has low metabolic activity (Leese, 2012) compared with the metabolic activity in the blastocyst or in adult tissues (Brinster, 1967a) . The mitochondria appear small and rounded, lacking cristae at the 1-to 2-cell stages but are well formed in later stages (Calarco and Brown, 1969) . Measurements of glucose metabolism (Brinster, 1967b; Lane and Gardner, 2000; Leese and Barton, 1984) have shown that glucose consumption in cleavage-stage pre-implantation embryos is often more than 10-fold lower than in blastocysts. Metabolic processes such as the TCA cycle are coupled to the overall energetics of the cell and are therefore also attenuated (Barbehenn et al., 1978; Houghton et al., 1996) . Similarly, the fate of metabolites consumed by the embryos is unusual. For example, only a fraction of pyruvate is completely oxidized in the mitochondria or reduced to lactate by lactate dehydrogenase (Lane and Gardner, 2000) Both lactate and pyruvate are present in the oviductal fluid and are included in similar proportions in the ex vivo growth medium. Zygotes fail to survive in medium lacking both lactate and pyruvate. However, if only pyruvate is left out of the growth medium, the embryo is viable but fails to develop beyond the 2-cell stage (Brown and Whittingham, 1991) . Under these conditions, lactate is not efficiently utilized because of the low NAD + /NADH ratio in the 2-cell embryo. Glucose is not substantially oxidized until the morula stage, and added glucose cannot be converted to pyruvate (Barbehenn et al., 1978; Brinster, 1969) . However glucose is also included in the growth medium to support the entire pre-implantation developmental program from 1-cell to blastocyst, in serum-free conditions (Biggers et al., 1967; Leese, 2012; Brown and Whittingham, 1991) . Embryos develop normally without requiring the import of proteins and amino acids from the medium, and, astonishingly, the 1-cell and 2-cell embryos complete their entire homeostatic processes even though amino acid accumulation, mitochondrial oxygen consumption, and glucose oxidation are all at very low levels (Brinster, 1969; Houghton et al., 1996) . Low metabolic activity at early stages is thought to keep ROS levels low, thus avoiding DNA damage at a totipotent stage (Baumann et al., 2007) . In this paper, we demonstrate that a subset of mitochondrial enzymes of the TCA cycle briefly localize to and are active within the nucleus of the early stage embryo and are essential for the production of key metabolites that play a role in epigenetic remodeling during zygotic genome activation and developmental progression beyond the 2-cell stage.
RESULTS

Pyruvate Requirement in Early Stages of Embryogenesis
The first step in this study was to optimize the conditions of growth in a medium that is devoid of all amino acids or proteins and yet capable of sustaining pre-implantation development. Since the standard KSOM medium contains both, we developed a modified medium (mKSOM) (STAR Methods) that only contains the metabolites lactate, glucose and pyruvate, plus salts/buffer, and poly vinyl alcohol (Lawitts and Biggers, 1991) . Zygotes are isolated 18 hr posthCG injection (STAR Methods) and cultured either in mKSOM medium that contains pyruvate (called +P medium for simplicity) or in mKSOM lacking pyruvate (or -P medium). Embryos grown in +P medium transition at the proper rate to the blastocyst stage ( Figures 1A-1D ), while those grown in -P medium are arrested at the 2-cell stage . A subset of embryos is blocked at the 1-cell stage in -P. These results are consistent with earlier studies that have used slightly different media (Biggers et al., 1967; Brown and Whittingham, 1991) . By switching the medium between +P and -P at various time points (Figure S1 ), the critical period for the pyruvate requirement is mapped to a 30-hr window between 24 and 54 hr ( Figures 1I-1K 0 ). At times outside this window, lactate substitutes pyruvate for normal development. All timings reported as hours in this paper are hours post-hCG ( Figure 1I ).
Bromodeoxyuridine (BrdU) incorporation and proliferating cell nuclear antigen (PCNA) expression, marking the S phase of the 2-cell stage, remain unchanged between embryos grown in +P or -P media ( Figures 1L-1O ). phospho-Histone3 (PH3) is first detected at very low levels at 45 hr in both +P and -P media ( Figures  1P and 1Q) . However, at 54 hr, late G2 phase, PH3 staining rises dramatically in +P but not in -P cultured embryos ( Figures 1R  and 1S ). Consequently, pyruvate-deprived 2-cell embryos do not enter M phase, characterized by spindle assembly ( Figures  1T and 1U ).
Pyruvate Requirement in ZGA In mouse embryos, ZGA initiates during the G2 phase of the 2-cell embryo (Aoki et al., 1997) . As this is precisely the stage when the embryos arrest in the absence of pyruvate, we used several different strategies to explore whether these two events might be linked. 5-bromouridine 5 0 -triphosphate (BrUTP) assay to detect incorporation into newly synthesized transcripts (Aoki et al., 1997) revealed that, compared with embryos grown in +P medium, those cultured in -P fail to show any detectable BrUTP staining (Figures 2A-2C ). The phosphorylation status of Ser5 or Ser2 on the C-terminal domain of RNA Polymerase II is also an excellent measure of transcription-initiation as RNA Pol II requires these serine phosphorylation events in order to be part of the initiation and the elongation complex, respectively (Egloff and Murphy, 2008) . A significant reduction of Pol II Ser-5P and Pol II Ser-2P in -P embryos demonstrates that RNA Pol II is not engaged in transcription at the time of ZGA in +P embryos ( Figures 2D-2I ). Importantly, total RNA Pol II protein abundance is not affected by pyruvate deprivation (Figures S2A-S2D ). Finally, we compared the protein expression of SIRT1, the product of an early zygotic transcript, in +P and -P media. SIRT1 is robustly detected at the 2-cell stage when pyruvate is included in the medium but is eliminated when grown in the absence of pyruvate ( Figures 2J-2L ). Taken together, we conclude that exogenously supplied pyruvate is essential for activation of the zygotic genome. Lack of ZGA, in turn, is the likely cause of the cell-cycle block since artificially inhibiting DNA replication or cytokinesis does not eliminate ZGA, whereas preventing ZGA will stop the cell from developing beyond the 2-cell state (Schultz, 1993) .
Subcellular Localization of Enzymes Involved in Pyruvate Metabolism
Diverse functional assays of oxygen consumption, ATP generation, mitochondrial morphology, and measurement of membrane potential (Acton et al., 2004; Houghton et al., 1996; Trimarchi et al., 2000) have concurred that early stage mitochondria show low energetic activity compared to those in the blastocyst. Also, two distinct classes of early stage mitochondria are identified based on their membrane potential (Acton et al., 2004) . As (E-H) Embryos cultured in -P medium at (E) 24-hr zygote; (F) 48-hr 2-cell embryo; (G) 72-hr 2-cell arrested, and (H) 96-hr 2-cell arrested. (I) Cell-cycle phases in 1-and 2-cell embryos (adapted from Aoki et al., 1997) . (J and J 0 ) Zygotes cultured in -P (until 24 hr) and then shifted to +P (from 24 to 54 hr) and then shifted back to -P (54-hr blastocyst); these embryos develop normally and form blastocysts.
(K and K 0 ) In the converse experiment, zygotes cultured in -P medium (24-54 hr) and in +P (before 24 hr and after 54 hr) are arrested at the 2-cell stage.
(J-K 0 ) 30-hr window (24-54 hr) as necessary and sufficient for pyruvate dependence.
(L-O) Embryos at 38 hr cultured in +P (L) or -P (M) show identical 2-hr BrdU incorporation marking S phase. Similarly, PCNA staining, also marking S phase, is unchanged in +P (N) and -P (O) cultured embryos.
(P-S) G2 phase monitored by PH3 staining shows entry into this phase (at 45 hr) with very faint PH3 staining in both +P (P) and -P (Q) embryos. However at 54 hr, progression through G2 in +P (R) is marked by high PH3 staining, not seen in -P (Q).
(T-U) At 60 hr, tubulin expression highlights spindle assembly in +P (T) and the lack of it in -P (U). See also Figure S1 .
culture conditions and genetic backgrounds can affect mitochondrial function (Williams et al., 2016) , it was important for us to make sure that these previously well-established conclusions are also seen under our culture conditions. Indeed, we confirmed that when stained with JC1 dye, a small subset of mitochondria along the edge stain red (indicating high membrane potential), while the vast majority stain green (suggesting low membrane potential) (Figures 3A and 3B) . Similar results were obtained upon staining with the Ca 2+ concentration-sensitive dye Rhodamine 2AM, an independent marker of mitochondrial membrane potential ( Figure 3D ). JC1 and Rhodamine-2AM can penetrate the tissue since extensive mitochondrial staining is readily detected throughout the depth of the embryo at many developmental stages (e.g., Figures S3B and S3C) . As further controls, we verified that addition of carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP), a mitochondrial membrane un-coupler, causes loss of Rhodamine 2AM staining and conversion of all mitochondrial JC1 staining to green, indicating loss of membrane potential ( Figures 3C and 3E ). The absolute requirement of pyruvate for development seems to be at odds with the low bioenergetic activity of the early embryo. We therefore examined the activation status of the mitochondrial enzyme PDH that enables conversion of pyruvate to acetyl-CoA. PDH-kinase (PDK) phosphorylates the PDH-E1a subunit and renders the PDH enzyme complex inactive (Holness and Sugden, 2003) . A corresponding phosphatase, called PDHphosphatase (PDP), reverts PDH to its active, non-phosphorylated form (Holness and Sugden, 2003) . The expression patterns of PDK and PDP can provide valuable information about the activation status of PDH.
In the oocyte, PDK protein is at marginally detectable levels ( Figure S3D ), increasing somewhat at pronuclear stages PN2-3 and PN4-5 ( Figure S3E ). Truly robust expression of PDK is evident in the mitochondria of 2-cell embryos (Figures 3F and S3F) . It is unusual to see such high PDK levels in non-glycolytic cells, and the resulting attenuation of PDH activity will decrease TCA cycle flux. This is consistent with low bioenergetic activity of the 2-cell embryos.
The activity pattern of PDH can also be directly judged by staining with a series of antibodies. The first, generated against the phosphorylated epitope of PDH-E1a, specifically recognizes the inactivating phosphorylation site (called a-PDH inactive here).
This antibody has been extensively used to detect inactive PDH in both in vivo and in vitro assays (Donohoe and Bultman, 2012) . Staining with a-PDH inactive decorates a majority of the mitochondria in the 2-cell embryo , indicating that mitochondrial PDH is largely inactive. As controls, the PDK blocker dichloroacetate (DCA) suppresses a-PDH inactive staining and raises the mitochondrial Ca 2+ level ( Figures  S3I-S3K) .
A second antibody, generated against the N-terminal 131 amino acids (31-161) of PDH E1a protein, recognizes both the active and the inactive forms of the protein (called a-PDH total here; Sutendra et al., 2014) . Immuno-staining with a-PDH total reveals that total PDH is localized not only to the mitochondrion, but also prominently in the nuclear compartment ( Figures 3H  and 3I ). Nuclear PDH is not recognized by a-PDH inactive and is therefore un-phosphorylated and likely active. Screening among the large collection of commercially available PDH antibodies, we found one (Tomilov et al., 2014 ) that specifically recognizes this nuclear component ( Figures 3J-3L ). We refer to this antibody as a-PDH nuc . This same antibody exclusively stains mitochondria at the blastocyst stage ( Figure S3L ) as is also true of the a-PDH total staining ( Figure 3M ) suggesting that a-PDH nuc likely Figure S3 .
recognizes the active PDH enzyme that is nuclear at the 2-cell and mitochondrial at the blastocyst stage. The E2 and E3 subunits of PDH also show dual localization to the mitochondrion and the nucleus ( Figures S3M and S3N ). The nuclear localization of PDH initiates during the S phase of the mitotic cycle based on timing as well as co-localization with PCNA ( Figures S3O-S3V ). PDH is first detected at PN3 and PN4 stages of the 1-cell embryo. Following mitosis, nuclear PDH is extremely low during the short G1 phase of the 2-cell embryo but is robustly nuclear during the S phase (marked by PCNA staining, Figures S3R-S3V ) and in the prolonged G2 phase that follows ( Figure S3T ). Strikingly, in-vivo-isolated 4-cell embryos occasionally show two of the cells with mitochondrial localization and the other two with largely a nuclear pattern, while other embryos from the same collection show identical, nuclear localization pattern in all four cells (Figures S3W and S3X) . As each pair of cells of a 4-cell embryo can be slightly asynchronous in their cell cycle with the other, these results suggest that nuclear localization follows the final cyclic pattern at the 4-cell stage. Also, these images indicate an exchange of the enzyme between the mitochondrial and nuclear compartments. Pyruvate has multiple roles within the cell. One unexpected role, relevant to the current context, is revealed upon staining with PDH antibodies in a pyruvate-deprived embryo. In contrast to embryos grown in the normal +P medium, those that are grown without pyruvate (-P medium) show a complete lack of nuclear PDH ( Figures 3N-3P ). Further support for the involvement of pyruvate in nuclear localization is suggested by rescue experiments. Embryos cultured until the late 2-cell stage without pyruvate, when returned to a +P medium, and cultured for an additional 12 hr, show partial rescue of nuclear PDH ( Figure 3Q ). However, the 2-cell mitotic block is not rescued by this delayed pyruvate addition (data not shown).
Conversion of phosphorylated PDH-E1a to an active un-phosphorylated form requires pyruvate dehydrogenase phosphatase (PDP). Antibody staining reveals that PDP is localized to the nucleus at the 2-cell stage ( Figure 3R ). The exclusive localization of PDK to the mitochondrion ( Figure 3F ) and PDP to the nucleus ( Figure 3R ) indicates a concerted regulatory mechanism that keeps the mitochondrial PDH relatively inactive and the nuclear PDH complex active at this specific stage of development. Later in the paper, we describe a functional assay directly demonstrating that the nuclear component of PDH is indeed enzymatically active.
Localization of Pyruvate Carboxylase and Enzymes of the TCA Cycle
The metabolite citrate is very abundant in the early mouse preimplantation embryo compared to that usually seen in somatic cells (Barbehenn et al., 1978) . Citrate is generated by the condensation of the metabolites acetyl-CoA and oxaloacetate (OAA). In principle, pyruvate can be converted to acetyl-CoA by PDH; additionally, pyruvate can be directly converted to OAA in the presence of pyruvate carboxylase (PCB) (reviewed in Holness and Sugden, 2003) . Indeed, early embryonic PCB activity has been reported in the literature (Quinn and Wales, 1974) .
Upon immuno-staining for PCB, we found a fraction of it to be present in the nucleus ( Figure 4C ). Unlike for PDH, antibodies that discriminate between active and inactive versions of PCB, or the other enzymes described in this section, are not available. Although the nuclear staining is clearly discernable, the stronger mitochondrial component makes it harder to tell apart from that in the nucleus. We followed four steps to establish nuclear localization. First, we isolated and immediately fixed single nuclei from the embryos (see STAR Methods), stained them with the antibody and with DAPI, and imaged them directly. This would prevent any artifacts due to spillover staining or saturation issues with microscopy due to the dominant mitochondrial staining. Second, to ensure that the nuclear staining is not an artifact of the ex vivo culture system, we isolated older, 2-cell embryos instead of zygotes, directly from the mother by adjusting the collection time, and fixed and stained them with no time spent in culture. Third, we cultured embryos in +P and -P media followed by immunohistochemistry to determine whether the enzyme, as for PDH, requires pyruvate for nuclear localization. Finally, we repeated our staining protocol on multiple embryos to quantitate the strength of staining with and without the presence of pyruvate.
Following this protocol, we determined that isolated nuclei show the presence of PCB ( Figures 4A and 4A 0 ), 2-cell embryos from in vivo collection show nuclear localization ( Figure 4B ) similar to that seen following culture in +P medium (Figure 4C) , and that the nuclear localization of PCB is entirely pyruvate dependent (Figure 4C 0 ). Quantitation of multiple isolates clearly established that the pyruvate dependence is statistically significant (Figure 4C 00 ). In principle, nuclear PCB and PDH could metabolize pyruvate to generate OAA and acetyl-CoA, respectively, in the nucleus. To make citrate, however, involves the enzyme citrate synthase (CS) that is a component of the TCA-cycle not known to have any extra-mitochondrial function. Nevertheless, following the four steps elaborated above for PCB, we found that a fraction of the CS enzyme also localizes to the nucleus ( Figures 4D-4F ) in a pyruvate-dependent manner (Figures 4F-4F 00 ). While nuclear localization of PDH has been reported in other systems (Chueh et al., 2011; Sutendra et al., 2014) , nuclear localization of a TCA cycle enzyme such as citrate synthase is an unexpected finding and led us to investigate the 2-cell embryo localization status of all TCA cycle enzyme isoforms that normally function in the mitochondrion. Beyond CS, the next TCA cycle step uses the mitochondrial enzyme aconitase 2 (ACO2) to metabolize citrate to iso-citrate. ACO2 expression is distinctly nuclear in a pyruvate-dependent fashion at the 2-cell stage ( Figures 4G-4I 00 ). Next is the enzyme mitochondrial isocitrate dehydrogenase (IDH3), which uses isocitrate as a substrate to generate a-ketoglutarate (a-KG), an important metabolite required for DNA and histone demethylation enzyme function (Xiao et al., 2012) . IDH3 is also nuclear at this stage of development only in the presence of pyruvate ( Figures 4J-4L 00 ). None of the above enzymes is nuclear at later stages such as in the blastocyst where the same antibodies detect them exclusively in the mitochondrion ( Figures 4M-4P ). The next set of TCA cycle enzymes is either detected at very low levels in the nucleus (KGDH, Figures 4Q 0 ) even in the presence of pyruvate. Finally, embryos isolated after in vivo development to the 2-cell stage and then immediately fixed and stained with SDHA antibody gave no detectable signal in the nucleus, as was seen for the cultured embryos (Figure 4U) . Important positive and negative specificity controls are described in Figure S4 .
Nuclear transport of the TCA-cycle-related enzymes not only requires the presence of pyruvate, but requires mitochondrial entry of the supplied pyruvate ( Figures S4M and S4N) . A func- I, 00 and L 00 ) Quantitation of data comparing intensity of nuclear staining in (+P) and (-P) grown embryos. In all four instances, p value is <0.0001(nuclei n = 18 PCB, n = 16 for CS, n = 16 for Aco-2, and n = 12 for IDH3A). Clear evidence for pyruvatedependent nuclear localization is evident for the enzymes pyruvate carboxylase (PCB) (A-C 00 ), citrate synthase (CS) (D-F 00 ), mitochondrial aconitase-2 (Aco-2) (G-I 00 ), and mitochondrial isocitrate dehydrogenase 3A (IDH3A) (J-L 00 ). tional protein translation machinery is equally essential for maintaining the mitochondrial and the nuclear levels of PDH (Figures S4O and S4P) . We propose that, in addition to its role in maintaining energy homeostasis, mitochondrial pyruvate plays an independent role in facilitating the enzyme complex transport process. This model is supported by additional experiments, discussed later in the paper.
In summary, in the 1-to 2-cell stages of mouse pre-implantation embryo, half of the TCA cycle proteins, CS, ACO2, IDH3, and also PDH, PCB are readily detected in the nucleus (in addition to the mitochondria). Collectively, we designate these as class I (TCA cycle related) enzymes, whereas the enzymes that function (B-G) Isocitrate dehydrogenase activity in nuclei isolated from 2-cell embryos. DAPI (blue) identifies individual nuclei, fluorescence generated by reduction of cyano-tetrazolium dye is indicative of IDH activity and is shown in red. (B and C) Nuclei (n = 76) from +P embryos assayed in complete assay solution are positive for IDH activity (red). (D and E) Nuclei (n = 86) from -P embryos assayed in complete assay solution; absence of signal in (E) confirms pyruvate dependence. (F and G) Nuclei (n = 72) from +P embryos evaluated in assay solution without isocitrate; absence of signal in (F) shows specificity of the assay for IDH that converts isocitrate to a-KG.
(H) 2-cell embryos are starved for 30 min in medium lacking pyruvate, lactate, and glucose. Metabolite levels are compared to control embryos moved for 30 min to a fresh medium including pyruvate but lacking glucose and lactate. Citrate (p = 0.021), aconitate (p = 0.0056), and alpha-ketoglutarate (p = 0.0098) levels in starved samples are significantly lower than in control. In contrast, succinate levels increase (p = 0.0087) and malate (p = 0.35) and fumarate levels do not change (p = 0.25). Data are presented as the means ± SD; n = 3; each biological replicate contains more than 200 embryos. (I) Starved embryos are re-fed with pyruvate for 20 min. Citrate (p = 0.0039), aconitate (p = 0.0038), and alpha-ketoglutarate (p = 0.0026) levels recover (increase) significantly following re-feeding. In contrast, re-feeding has little effect on succinate (p = 0.99) and malate (p = 0.061) and even caused a significant drop for fumarate (p = 0.002). Data are presented as the means ± SD; n = 3; each biological replicate contains more than 200 embryos. (J) Pyruvate dependence of TCA cycle metabolite levels at 48 hr. The steady-state levels of all metabolites are lower in -P compared with +P control. However, the drop in citrate, aconitate, and a-KG levels is more substantial than that seen for succinate, fumarate, and malate. Data are presented as the means ± SD, n = 3, with each replicate containing at least 100 embryos.
(legend continued on next page) later in the TCA cycle that we call class II enzymes remain strictly mitochondrial. Given the low activity of the TCA cycle, in the mitochondrion, in principle, nuclear localization of class I enzymes affords the ability to generate metabolites: acetyl-CoA, citrate, isocitrate, and a-KG that are important for ZGA directly within the nucleus. Collectively, we call them class I metabolites. The products of the class II enzymes (class II metabolites) should present a very different profile in the context of 2-cell development. This was next tested by multiple assays for enzyme function and metabolite levels.
Activity Assays in Isolated Nuclei for Key Mitochondrial Enzymes
We have shown that nuclear PDH complexes are largely unphosphorylated and therefore predicted to be catalytically active. The first step in this enzymatic activity involves the decarboxylation of pyruvate and generates CO 2 derived from the carbon at position 1 of pyruvate. To directly assay this activity, we adapted a technique previously described for larger sample sizes (STAR Methods; Sies et al., 1983; Williamson et al., 1979) to work with isolated nuclei from 2-cell embryos ( Figure 5A ). This direct enzymatic assay demonstrates active decarboxylation of pyruvate within the nuclei. Combined with the observation that nuclear PDH remains un-phosphorylated, the labeling assay allows us to conclude that PDH detected in the nucleus is catalytically active. Consistent with these results, lipoic acid modification, essential for PDH complex function, is detected in the nucleus in the presence of pyruvate ( Figures S5A and S5B) . IDH3 is the last of the class I enzymes, and it converts isocitrate to a-KG, in the process generating NADH from NAD + . The production of NADH was monitored using a nitro-tetrazolium dye (cyano-tetrazolium), which fluoresces red and precipitates upon reduction (Dikov et al., 2004) . Embryos cultured in the +P but not -P medium have active IDH3 in their nuclei ( Figures  5B-5E ). Importantly, the IDH3 signal requires the presence of isocitrate and NAD + (Figures 5F and 5G) (but not NADP + ; see STAR Methods) in the assay solution reaction. Thus, key class I mitochondrial enzymes are catalytically active within the nuclei of 2-cell embryos.
Metabolite Measurements
Classic cycling assays (Barbehenn et al.,1978) have suggested that metabolite dynamics in glycolysis can be efficiently analyzed by starving cells for a short period of time to measure changes and then re-feeding them to estimate metabolite recovery. Adapting this assay for measuring TCA cycle metabolites using a highly sensitive capillary ion chromatography method for separation, followed by high-resolution mass spectrometry (see STAR Methods), we were successful in measuring small quantities of most TCA cycle metabolites in approximately 300 embryos. Metabolite levels were measured (1) following incubation in +P medium with no starvation, (2) after a brief 30-min starvation in medium lacking glucose, pyruvate, and lactate, and (3) following 20-min recovery in medium containing pyruvate (but not lactate and glucose). Of the TCA cycle metabolites, citrate, aconitate, and a-KG levels are significantly reduced upon starvation and significantly restored during the short, 20-min, refeeding session (Figures 5H and 5I) . Remarkably, succinate, fumarate, and malate, which are generated by enzymes that are not localized to the nucleus, are not diminished following starvation nor do their levels rise following re-feeding with pyruvate ( Figures 5H and 5I ). The observation that malate levels, in fact, fall upon re-feeding is in agreement with earlier observations (Barbehenn et al., 1978) .
In a second analysis, we isolated zygotes, cultured them until the 2-cell stage under +P and -P conditions and then directly measured TCA cycle metabolites. Figure 5J shows that metabolites formed by enzymes present in the nucleus decrease significantly more in -P medium than metabolites formed by enzymes that are exclusively mitochondrial. Collectively, these data demonstrate that the TCA metabolites have different dynamic properties. Those generated by enzymes with a nuclear component are more dependent on the presence of exogenously provided pyruvate compared with metabolites generated by the later enzymes of the TCA cycle that are not detected in the nucleus.
Rescue Experiments a-KG is the terminal class I metabolite and in principle capable of producing earlier ones by conversion to citrate. Amazingly, we found that a cell-permeable analog of a-KG added to the -P medium supports development to the blastocyst stage and completely rescues the 2-cell block as well as transport of class I enzymes to the nucleus (Figures 5K-5O) .
Metabolite measurements show that the GSH/GSSG ratio, indicative of oxidative stress is unchanged in the absence of pyruvate ( Figure S5G ). However, the ATP/ADP ratio (Figure S5F ), the amount of ATP (Figure 5Q ), and the NAD + /NADH ratio ( Figure 5P ) are all affected if the growth medium lack pyruvate. Under normal growth conditions, these ratios are critical for embryonic development, and the redox ratio, in particular, is too low in the absence of pyruvate to support progress beyond the 2-cell (K-O) Percentage of 120-hr embryos forming blastocysts in a -P medium supplemented with a membrane permeable form of 1 mM a-KG. n = independent isolations with each isolation containing least ten embryos. -P n = 10, +P n = 24, a-KG n = 9 (K). Representative examples of a-KG rescued 96-hr blastocysts (L) . (M-O) A fraction of PDH is nuclear in +P (M) but not -P (N) cultured embryos. Nuclear localization is restored in -P medium supplemented with a-KG (O). (P and Q) Neither the lowered NAD + /NADH ratio (n = 5 cycling assays) (P) nor the lowered ATP concentration (Q) in pyruvate-deprived embryos is rescued by a-KG supplementation of -P medium even as developmental and nuclear localization defects (K-O) are completely rescued. p values: +P to -P (p = 0.0199). +P to a-KG (p = 0.0125). -P to a-KG (p = 0.6355). n = 3 independent isolations of embryos.
(R) The percentage of 120-hr embryos forming blastocysts following culture in -P medium supplemented with each indicated amino acid (1 mM). Proline fully and arginine partially rescue the pyruvate defect. n = independent isolations, with each isolation containing least ten embryos. -P n = 10, +P n = 24, proline n = 8, arginine n = 6. (S) The lowered NAD + /NADH ratio upon pyruvate deprivation is not rescued by proline supplementation (n = 4 cycling assays). Thus, pyruvate-deprived embryos continue to be under energetic and redox stress with supplemented a-KG, even as the 2-cell block and ZGA are rescued. Data are presented as the means ± SEM, unless otherwise stated. See also Figure S5 .
stage. Interestingly, and somewhat unexpectedly, we found that the embryos rescued with a-KG-supplemented -P medium continue to exhibit reduced NAD + /NADH ratio ( Figure 5P ) and reduced ATP levels ( Figure 5Q ) similar to embryos cultured in -P media rather than those grown in +P. Thus, a-KG does not rescue the developmental phenotype by lessening the changes in energetic or redox balance due to the absence of pyruvate. It is doing so by providing the essential carbon, normally provided by pyruvate, required for downstream anabolic processes.
Within the cell, catabolism of amino acids can generate a-KG. We therefore asked whether non-essential amino acids rescue -P embryo phenotypes. Interestingly, the only two that are capable of such a rescue are proline and arginine, both known to generate a-KG ( Figures 5R, S5C, and S5D) . None of the other non-essential amino acids substantially rescues the phenotype, including alanine and serine that can generate pyruvate ( Figure 5R ). Similar to a-KG, proline does not rescue the NAD + /NADH ratio or ATP levels while rescuing the 2-cell block, once again demonstrating that early embryos can develop into blastocysts even under redox ( Figures 5P and 5S ) and energetic stress ( Figures 5Q and S5C-S5E ). Figure 6A summarizes our results thus far that establish that a fraction of class I mitochondrial enzymes are transiently nuclear producing class I metabolites favorable to epigenetic changes that lead to genome activation. Class II enzymes are not similarly dynamic in producing class II metabolites ( Figure 6A ). The mechanism for moving large enzyme complexes from the mitochondrion to the nucleus is not fully clear (see Discussion), but our data point to an important role for O-linked glycosylation in this process. In +P media, O-glycosylated proteins are located inside the nucleus and on the nuclear membrane ( Figure 6B ). The localization inside the nucleus is virtually eliminated in -P embryos with the nuclear membrane component relatively unchanged ( Figures 6B-6D ). Although the majority of nuclear protein import relies on canonical nuclear localization signals (NLSs), other mechanisms exist (Lange et al., 2007) . For example, an alternative mechanism involves O-linked glycosylation of the transported protein, followed by binding to a chaperone molecule such as Hsp90 or Hsp70, and the subsequent transport of this complex through the heavily glycosylated pores on the nuclear membrane (Guinez et al., 2005; Duverger et al., 1996) . The enzyme necessary for transferring the O-glycosyl moiety derived from UDP-GlcNAc to the target protein is O-linked N-acetyglucosamine transferase (OGT). In +P medium, OGT is seen in the nucleus, as well as in cytoplasmic punctae, but in -P embryos, OGT is no longer nuclear ( Figures S6A-S6F) . Additionally, the inhibitor STO45849 that specifically blocks OGT function causes loss of PDH nuclear localization ( Figures 6E-6G ), a reduction in O-glycosylation and a 2-cell block ( Figures S6M-S6P ). The chaperon proteins HSP70 and HSP90 are prominently expressed at this stage ( Figures S6G and S6H) , and most strikingly, a specific inhibitor of HSP90, 17-AAG, gives rise to a 2-cell block in development ( Figures S6Q-S6T ) and prevents nuclear localization of PDH ( Figures 6H-6J) . Thus, one potential model is that pyruvate-dependent acetylation of glucosamine-6-phosphate is a key step in the formation of O-glycosylated mitochondrial enzymes that utilize a chaperone-dependent transport process to locate within the nucleus (see Discussion for alternatives).
Role of O-linked Glycosylation in Nuclear Localization
Pyruvate-Dependent Histone Modifications
A number of epigenetic changes linked to genome activation will require appropriate metabolites that help add or delete acetyl or methyl groups to histones (Martinez-Pastor et al., 2013) . We find that pyruvate-deprived embryos show a virtual elimination of H3K4 acetylation (Figures 6K-6M ), a reduction in H3K27 acetylation ( Figures 6N-6P) , and an almost complete elimination of H3K27 trimethylation (Figures 6Q-6S ). Global acetylation of other sites such as H3K9, H3K14, or H4K5 or trimethylation of H3K4 and H3K9 remains unchanged ( Figures S6U-S6X 0 ).
PDH Localization in Human Embryos
The surprising finding that the first half of the mouse TCA cycle enzymes are detected in the nucleus at the 2-cell stage led us to investigate whether a similar mechanism might operate in human embryos. A conserved mechanism would be relevant to human fertility and in vitro fertilization protocols, and we were therefore granted access to a small number of human embryos from fertilization clinics, through a fully consented and documented process. Due to the very limited tissue availability, we have restricted our study to the localization of PDH to serve as a guide. A mixture of two sets of antibodies, described earlier, was used: a-PDH inactive (recognizes only the inactive phosphorylated version) and a-PDH total (recognizes both active and inactive forms). Unlike in mouse, neither 1-cell pronuclear fusion stage ( Figures 7A-7C ) nor 2-cell stage ( Figures 7D-7F ) human embryos show any evidence of nuclear PDH. Similar to that seen in mouse, mitochondrial PDH detected in the human embryo is largely phosphorylated (inactive). At the 4-cell and peaking at the 8-cell stage, a burst of nuclear PDH active becomes readily detectable ( Figures 7G-7R) , and a single stage later, in the morula, there is no longer a hint of nuclear PDH active in the human embryo ( Figures 7S-7U ). Thus, in mouse embryos, nuclear PDH initiates at 1-cell, peaks at 2-cell and starts declining beyond the 4-cell stage. In contrast, human embryos initiate nuclear PDH localization at the 4-cell stage, peaking at the 8-cell stage, and is excluded from the nucleus in the morula. Nuclear PDH is never detected in the morula or blastocyst of either mammal. Remarkably, the delayed nuclear entry in the human compared to the mouse embryo corresponds exactly to the natural ZGA timing, which takes place in the mouse, at the late 2-cell stage, and in humans, between the 4-cell and 8-cell stages (Niakan and Eggan, 2013; Xue et al., 2013) .
DISCUSSION
This paper investigates the relationship between the metabolic status and developmental progression of mouse pre-implantation embryos. The central finding is that multiple TCA cycle and associated enzymes are temporarily localized to the nucleus, while also maintaining a mitochondrial pool. Functional analysis indicates that such proteins (class I enzymes) are enzymatically active within the nucleus. These enzyme complexes are the ones that belong to the first half-cycle of the TCA cycle, and the data support a model in which they are important contributors of metabolites (class I metabolites) such as acetylCoA and a-KG essential for epigenetic control and activation of the zygotic genome during the 1-to 2-cell stage of pre-implantation development ( Figure 6A ). The enzymes in the second half of the TCA cycle (class II enzymes) are not seen in the nucleus and their corresponding class II metabolites such as succinate and fumarate are not favorable for genome activation (Xiao et al., 2012) . Strong support for the model is provided by the rescue of the developmental and transport defects due to pyruvate deprivation by exogenously provided a-KG. Our results show that, at the 1-and 2-cell stages, PDH (that converts pyruvate to acetyl-CoA) is localized both to the mitochondrion and the nucleus. The enzyme PDK (that inactivates PDH) is localized to the mitochondrion, while PDP (the activator of PDH) is largely confined to the nucleus. The simplest explanation is that the PDK in the mitochondrion renders PDH less active than at later stages of development, while the PDH that enters the nucleus is activated by PDP. The most significant finding of this paper is that multiple enzymes of the TCA cycle and additional proteins related to entry into the TCA cycle: pyruvate carboxylase, pyruvate dehydrogenase, pyruvate dehydrogenase phosphatase, citrate synthase, aconitase-2, and isocitrate dehydrogenase 3A (class I enzymes) are all transiently seen in the nucleus. The nuclear localization of TCA components is not (D) . (E-G) The OGT inhibitor, STO45849, blocks nuclear accumulation of PDH (E and F). p < 0.0001(nuclei n = 10) (G). (H-J) 17-AAG specifically blocks HSP90 function and causes loss of nuclear PDH (H and I). p < 0.0001(nuclei n = 10) (J). Consequently, both inhibitors cause a 2-cell block (Figures S5M-S5T ). (K-M) Robust H3K4 acetylation is seen in +P (K) but not in -P (L) embryos. p < 0.0001 (nuclei n = 14) (M). (N-P) H3K27 acetylation (N) is partially suppressed in -P medium (O), p = 0.0027 (nuclei n = 8) (P). (Q-S) H3K27 trimethylation in embryos cultured in +P (Q) is significantly reduced in -P (R) medium. p < 0.0001 (nuclei n = 14) (S). All other acetylation and trimethylation marks tested remain unchanged ( Figures S6U-S6X 0 ).
Data are presented as the means ± SEM. See also Figure S6 .
an artifact of the ex vivo culture conditions since identical results are obtained from embryos isolated at different stages of in vivo development and never subject to the ex vivo culture conditions. Enzyme activity assays adapted for very small number of isolated nuclei established that the enzyme complexes PDH and IDH3, the initiating and terminal class I enzymes are active inside the nucleus. Both dynamic measurements following brief pyruvate starvation and re-feeding as well as steady-state measurements in the presence and absence of pyruvate show a clear distinction in the dynamic property and pyruvate responses of class I and class II metabolites.
Nutrients such as pyruvate are essential for many independent functions within the cell. In this context, the rescue of ZGA and post-2-cell development by a-KG provides a unique perspective. The cells deprived of exogenously provided pyruvate continue to be under redox and energetic stress and yet are able to proceed through ZGA when a-KG is supplied. It is pertinent that the rescue by a-KG requires the presence of lactate. This observation suggests that lactate can be utilized in the absence of pyruvate, but, due to the low NAD + /NADH ratio, the rate of lactate to pyruvate conversion is not sufficiently high to maintain class I metabolite levels. Currently, it is unclear at which point the perturbed NAD + / NADH ratio limits lactate utilization. It is likely that the conversion of lactate to pyruvate by LDH is affected, but it is also possible that subsequent steps of the pathway are also limited. The decrease in the levels of class I metabolites will compromise the important biosynthetic and signaling processes that drive developmental progression and are fueled by carbon from lactate and pyruvate. The provision of exogenous a-KG supplies a portion of the carbon requirement of these processes, rendering the redox state less critical, allowing the embryos to progress beyond the 2-cell stage even under energetic or redox stress. It is surprising that proline is able to rescue development, but glutamine is not. Our preliminary (unpublished data) metabolite measurements suggest that exogenously provided a-KG or proline raises glutamate level in the embryo, but, for reasons still unclear, providing glutamine is much less effective in causing this change. Most strikingly, we also detect active (unphosphorylated) PDH in the nucleus of human embryos at a stage that is different from that seen in mouse, but one that precisely matches the timing of genome activation in humans. Thus, this entire process linking nuclear localization of TCA enzymes to ZGA seems to be conserved. But this also raises some difficult questions. Our first-level model was that class I enzyme entry into the nucleus aids in ZGA. The human embryo results suggest instead that some other signaling event marking ZGA timing instructs pyruvate-dependent nuclear transport. The simplest model for the trigger would be one that responds to nutrition levels, but this needs to be investigated further.
TCA enzyme complexes are large and require complex folding patterns. Several possible models, to be investigated in the future, can be proposed for the mechanism of their transport to the nucleus. The recently characterized ''mitochondrial-derived vesicles'' (MDVs) (Sugiura et al., 2014) could play a role in this process. These vesicles facilitate translocation of mitochondrial matrix proteins to several organelles including peroxisomes and lysosomes. While a possible involvement of MDVs in nuclear transport has not been explored, electron microscopy (EM) studies have shown that the early embryo displays a ring of mitochondria closely apposed to the nucleus and displaying a ''blebbing'' of vesicles into the nucleus (Szö llö si and Szö llö si, 1988). Only a fraction of TCA enzymes are involved in the transport process, but MDVs are reported to be selective for their cargo (Shutt and McBride, 2013) . Another model involves pyruvate-dependent O-glycosylation of class I enzymes binding to Hsp90 or similar chaperones and then gliding through the nuclear pore (Hardivillé and Hart, 2014) . This mechanism does not exclude a role of MDV-like vesicles in the transport process.
Published literature provides precedence for extra-mitochondrial localization of PDH (Chueh et al., 2011; Mitra et al., 2005; Sutendra et al., 2014) . Similar to our results in the pre-implantation embryo, all three subunits of PDH can be detected during the S phase of the cell cycle in the nucleus of lung cancer cell lines (Sutendra et al., 2014) . Also, this nuclear PDH enzyme complex is active and influences only a subset of histone acetylation patterns (Sutendra et al., 2014) . Notable differences include the need for large amounts of growth factors for nuclear PDH to be detected in cancer cell lines and, more importantly, that no TCA cycle enzyme such as citrate synthase and IDH, that were included in the study, were detected in the nucleus. These differences between the embryo and the cancer cell lines will be important in resolving questions regarding metabolic control of normal development and cancer. It will also be very interesting to determine whether the process outlined here for normal development is found either in part or in full in the context of any other cancer or stem cell development. An additional avenue to explore will be to determine whether these observations have clinical relevance in infertility research, including the efficiency of the in vitro fertilization procedures. Infertility is often associated with metabolic disorders and cellular stress signals. Whether some of these dysfunctions result from perturbation of processes described here warrants future analysis.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Mouse anti-PCNA Abcam Cat#ab29
Rabbit anti-phosphohistone 3 Abcam Cat#ab47297
Rat anti-tubulin Abcam Cat#ab6160
Mouse anti-Pol II Santa Cruz Cat#8WG16
Rabbit anti-Sirt1 Abcam Cat#ab7343
Mouse anti-O-linked glycolysation antibody (RL2) Abcam Cat#ab2739
Rabbit anti-H3K4 acetylation Abcam Cat#ab113672
Rabbit anti-H3K27 acetylation Abcam Cat#ab45173
Mouse anti-H3K9 acetylation Abcam Cat#ab12179
Mouse anti-H3K4 tri-methylation Abcam Cat#ab12209
Rabbit anti-phospho-PDH Abcam Cat#ab92696
Mouse anti-PDH Abcam Cat#ab110334
Mouse anti-PDH Santa Cruz Cat#sc-377092
Rabbit anti-PDK1 antibody Abcam Cat#ab52893
Goat anti-PDP1 antibody Santa Cruz Cat#sc87354
Mouse anti-PCB antibody Abcam Cat#ab110314
Rabbit anti-CS antibody Abcam Cat#ab96600
Mouse aconitase 2 antibody Abcam Cat#ab110321
Rabbit anti-IDH3A antibody Abcam Cat#ab58641
Goat 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mouse embryo culture All animal care and procedures used in this study are approved by the Animal Regulatory Committee (ARC) of the University of California at Los Angeles (UCLA). Mouse zygotes and pre-implantation embryos were collected from super-ovulated 4-week old C57BL/6J X C3He (Jackson labs) F1 females. Mice were super-ovulated by peritoneal injection of 7.5 IU of PMSG (Pregnant Mare Serum Gonadotropin) to stimulate egg production, followed by 7.5 IU of hCG (human Chorionic Gonadotropin) 48hrs after PMSG. Embryos were obtained by mating the super-ovulated females with C57BL/6 X C3He F1 males. Mating was confirmed by the presence of vaginal plug. For isolation of fertilized 1-cell zygotes, super-ovulated females were euthanized 18hrs post-hCG and zygotes were dissected out of the ampulla in the oviduct. The embryo-cumulus complexes were treated with 300 mg/ml of hyaluronidase to disperse the cumulus cells, washed in mKSOM medium without pyruvate and transferred to the appropriate culture medium (+P or -P) and cultured at 37 C in 5% CO 2 . For embryo isolation at later stages, the embryos were flushed from the oviduct at the appropriate times, washed in mKSOM medium and either cultured or fixed immediately for immuno-fluorescence analysis. All mouse embryos used in this study were cultured in a modified KSOM medium whose composition is identical to KSOM in salts, glucose, lactate and pyruvate (95mM NaCl, 2.5mM KCl, 0.35mM KH 2 PO 4 , 0.20mM MgSO 4 , 25mM NaHCO 3 , 1.71mM Cacl 2 , 0.01 mM EDTA, 0.20mM glucose, 10mM lactate, 0.20mM pyruvate) but was devoid of all amino acids and BSA. The osmolarity of the medium was maintained using 0.1% PVA (poly vinly alcohol) (Biggers et al., 1997) .
Human embryo culture
The human embryo studies were approved by the full UCLA Institutional Review Board (IRB#11-002027) and the UCLA Embryonic Stem Cell Research Oversight (ESCRO) Committee . Human pre-implantation embryos for this project were received cryopreserved from an IVF clinic following consent. A total of 10 2PN embryos from 2 donors were used for this project. Human embryos were slow thawed using Thaw-Kit 1 (Vitrolife) according to the manufacturer's protocol. The embryos were cultured in drops of Continuous Single Culture media (Irvine Scientific) supplemented with 20% Quinn's Advantage SPS Serum Protein Substitute (Sage Media) for 0 to 4 sequential days at 37 C, 6% CO 2 and 5% O 2 . At varying stages of development from 2PN to compacting morula, the zona pellucida was removed with Tyrode's Acidified Solution (Irvine Scientific) and fixed in 4% paraformaldehyde for 30 min and stained with antibodies as in the previous protocol.
METHOD DETAILS Reagents
The following antibodies and drugs were used in this study. 
BrUTP incorporation
BrUTP incorporation was performed using the protocol described by Aoki et al., 1997 . BrUTP incorporation was also performed using the Click-iT RNA imaging kit from Invitrogen (cat no. C10330). Live embryos were incubated in 5-ethynyl uridine (EU) for 30mins for incorporation into nascent transcripts, following which they were fixed in 4% paraformaldehyde for 30mins at room temperature and permeabilized in PBST for 20mins. Click-iT cocktail was freshly prepared and the embryos were incubated in it for 30mins at room temperature protected from light. The embryos were subsequently washed in Click-iT reaction rinse buffer and incubated in To-Pro in PBS to mark the nuclei and mounted in Vectashield medium for microscopy.
Immunolocalization in isolated nuclei
Staining nuclei devoid of the surrounding cytoplasm followed the methods developed by Coonen et al., 1994 . Embryos are removed from the mKSOM medium, washed several times with PBS, transferred with minimal amounts of PBS to a microdrop of 0.01N HCl / 0.1% Tween20 in distilled sterile water on a glass slide. Within a few minutes the Zona and the cytoplasm begin to disintegrate and the nucleus becomes clearly visible and following removal of all the cytoplasm, the nuclei remain attached to the glass slide. The slides are washed with several rounds of PBS to remove the remaining cytoplasm. The attached nuclei are fixed with 4% paraformaldehyde, washed in PBST, and stained with specific antibodies.
Antibody staining for immunofluorescence
Staged embryos are fixed in 4% paraformaldehyde for 30 min at room temperature, permeabilized for 30mins in PBS with 0.4% Triton (PBST), blocked in PBST with 3% albumin for 30mins and incubated with the desired primary antibody in PBST plus 3% albumin (PBSTA) overnight at 4 C. The following day the embryos were washed in PBST four times for 10min each, blocked with PBSTA, incubated with the appropriate secondary antibody (1/300 dilution) overnight at 4 C. Embryos were washed again 3 times for 10min each in PBST. Nuclei were counterstained with To-Pro for 10mins, washed once again in PBST for 10mins, deposited on glass slides and mounted in Vecta-shield (Vector Laboratories) medium. Images were captured using a Zeiss LSM 700 confocal microscope. Data were quantified using the Prism software package, using a two-tailed unpaired t test. The numbers of embryos used for each experiment are reported in the Figure legend. Data are considered significant if p < 0.05, and the error bars are ± SEM.
JC1 and Rhod-2A staining Live 2-cell embryos were incubated in mKSOM containing 0.1 mg/ml of JC1 (Life Technologies) or 5 mM Rhod-2AM (Life Technologies) for 30 min in 5% CO 2 at 37 C. After incubation, embryos were washed several times in mKSOM, transferred to depression slides and mounted in the medium.
Measurement of metabolite levels ATP was measured using the ENLIGHTEN ATP assay system according to the manufacturer's instructions (Promega, WI, USA). Briefly, ATP was extracted from embryos using 2.5% TCA and neutralized with 0.1 M Tris-acetate buffer pH 7.75. Following addition of an equal volume of rL/L Reagent (Promega), luminescence was measured as readout for ATP levels. ADP was measured using the ADP-glo detection kit (Promega, WI, USA). Reduced glutathione levels were determined using the GSH-Glo bioluminescent assay (Promega, WI, USA). Embryos (in 10 mL mKSOM) were snap frozen in liquid nitrogen. The thawed samples were added directly to 2X GSH-Glo reagent containing a modified luciferin and glutathione transferase, and incubated in the dark for 30 min at room temperature. An equal volume of luciferin detection reagent was added and the luminescence detected after 15 min. NAD + and NADH levels were determined using the NAD + /NADH Glo cycling assay, according to the manufacturer's instructions (Promega, WI, USA). Briefly, both NAD + and NADH were extracted from the embryos in a carbonate buffered base solution containing 1% DTAB, 10 mM nicotinamide, 0.05% Triton X-100, pH 10.7. The embryos were freeze-thawed in liquid nitrogen and centrifuged through a filter with a 10kDa mW cut-off. Samples for NAD + determination were neutralized with 0.4 N HCl. Both NAD + and NADH samples were heated for 20 min at 60 C. The assay reagent was added to the samples, which were then incubated for 3 hr for cycling, after which the luminescence was determined.
The assay to measure the response of the TCA cycle metabolites to starvation and re-feeding was adapted from the approach of Lowry. For each condition, approximately 250 embryos were cultured in +P media until 48 hr post-hCG. Each condition was assayed in triplicate, with each replicate containing approximately 250 embryos, the exact number of which was used to normalize the data. For the fully fed condition, embryos were washed twice in a large volume of fresh +P media, but which lacked lactate and glucose, and incubated for 30 min. Following which, the embryos were incubated for a further 20 min in fresh +P media (lacking lactate and glucose but containing pyruvate) and then the metabolites were extracted using cold 80% methanol. For the starved condition, embryos were washed twice in starvation media (lacking pyruvate, lactate and glucose), incubated for 30 min, following which the embryos were washed with fresh starvation medium and the metabolites isolated. For the re-fed condition, following a 30 min starvation, embryos were incubated with +P media (containing pyruvate, but not lactate or glucose) for 20 min. The embryos were washed twice in fresh +P media (containing pyruvate, but not lactate or glucose) and the metabolites extracted using cold 80% methanol. For samples analyzed under steady state conditions (Figure 5J ), embryos were transferred into 80% methanol in 5 ml of +P or -P media, which contained 10 mM lactate. The lactate level in the media is in excess and therefore insensitive to culture conditions. In Figure 5J , the lactate level was used as an internal control (this was not possible in 5H,I since lactate was omitted from the media). Dried metabolites were re-suspended in 15 ml 50% ACN and 10 ml were injected for chromatographic separation using the Thermo Scientific Ion Chromatography System (ICS) 5000 coupled to a Thermo Scientific Q Exactive run in negative polarity mode. The gradient ran from 10 mM to 90 mM KOH over 25 min with a flow rate of 350 ml / min. The settings for the HESI-II source were: S-lens 50, Sheath Gas 18, Aux Gas 4, spray heater 320 C, and spray voltage À3.2 kV. Metabolites were identified based on accurate mass (±3 ppm) and retention times of pure standards. Relative amounts of metabolites were quantified using TraceFinder 3.3. Oxaloacetate and isocitrate could not be measured accurately using this approach with tractable numbers of embryos. The data were analyzed using the Prism software package. The difference between metabolites in each condition was compared using unpaired two-tailed Student's t tests.
Enzymatic Analyses in Isolated Nuclei
Nuclei were isolated from two-cell embryos as described above. PDH activity was measured by adopting a method described by Lane and Gardner to measure pyruvate oxidation in live embryos (Lane and Gardner, 2000) . In these experiments pyruvate dehydrogenase activity was measured by incubating 200 isolated nuclei with assay solution (50 mM MOPS pH 7.4, 0.2 mM MgCl 2 , 0.01 mM CaCl 2 , 0.3 mM thiamine pyrophosphate, 0.12 mM coenzyme A, 2 mM NAD+, 2.64 mM L-cysteine HCl) containing containing [1- 14 C] pyruvate 0.085 mCi/ml. Each condition was performed in triplicate (and each replicate contained 200 nuclei).The nuclei were attached to pre-cut coverslips that were fixed in the lid of a microcentrifuge vial and a 3 mL drop of assay medium was placed on the nuclei. The vial lid was placed on a vial containing 1.65 mL of 25 mM NaHCO 3 pre-gassed with 5% CO 2 in air, which trapped labeled CO 2 generated from pyruvate. Samples were incubated for 5 hr at 37 C. Controls included a 3 mL drop of assay medium on the lid without nuclei in order to control for spontaneous breakdown of the label. Total counts were determined by the addition of a 3 mL drop of medium straight into the 1.65 mL NaHCO 3 . After 5 hr the vials were opened, and 1 mL of the NaHCO 3 removed and placed into a scintillation vial containing 200 mL of 0.1 M NaOH. Vials were sealed and stored overnight. The following morning, 10 mL of scintillation fluid was added to each vial. The vials were vortexed and counted for 4 min each, and the results were normalized against the total number of counts in the assay medium. Quantification was performed using an unpaired two-tailed Student's t test. IDH3 assay Nuclei were isolated from embryos cultured either in +P or -P medium on a glass slide were washed in PBS twice and IDH3 activity was determined in situ using an enzymatic assay. The assay buffer (Tris pH 7.4 (50mM), Mg 2 SO 4 (1mM), NAD + (1mM), isocitrate (10mM), Cynoditoly Tetrazolium (500 mg/ml) (Polysciences 19292-100) and PMS (25 mg/ml)). For negative controls, isocitrate was eliminated from the assay buffer. The nuclei were incubated for 4 hr, washed in PBS several times and mounted on Vectashield medium and the images were collected using confocal microscope.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical parameters are reported in the figures and figure legends. Data is considered significant if p < 0.05 (see Method Details). Statistical analysis was performed using the Graphpad Prism 7 software. Figure S1 . Defining the Critical Period for Pyruvate Requirement, Related to Figure 1 The 30hr critical time window for pyruvate requirement is shown in Figures 1J and 1K . This interval was determined by transferring embryos from +P to -P culture media (A) and vice versa (B), at the indicated times, shown in this figure.
Supplemental Figures
The following was the distribution of embryos at different stages, for each experiment between 70-80 embryos were used and were cultured for 96 hr.
(A) (a) For the 18-54 hr +P to -P experiment, 70 embryos developed to the blastocysts, 3 were blocked at the 2-cell stage. (b) For the 24-54hrs +P to -P experiment, 72 embryos developed to the blastocyst stage, 6 were arrested at the 1-cell stage and 1-embryo at the 2-cell stage. (c) For the 18-42 hr +P to -P experiment, 26 embryos were blocked at the 2-cell stage and 44 embryos developed to blastocysts. (B) (a) 18-54hrs -P to +P experiment, 48 were blocked at 2-cell stage, 14 embryos were blocked at 1-cell stage and 3 embryos at 3-cell stage. (b) For 24-54 hr -P to +P experiment, 54 were blocked at 2-cell stage, 11 embryos were blocked at the 1-cell stage and 6 embryos at the 3-cell stage. (c) for the 18-42hrs -P to +P experiment, 36 embryos were blocked at the 2-cell stage and 44 embryos eventually developed to the blastocysts. 
